ARNI Insider Trading Activity and SEC Form 4 Filings
ARNI insider trading summary
No open-market insider purchases or sales of Arno Therapeutics, Inc (ARNI) have been reported on SEC Form 4 in the past 12 months.
Latest ARNI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 30, 2016 | S Donald Sussman | Insider | Sell | $0 (4,285,111 @ $0.00) |
| Oct 3, 2016 | David M Tanen | Secretary | Buy | $0 (142,857 @ $0.00) |
| Aug 15, 2016 | Tomer Kariv | Director | Buy | $0 (349,168 @ $0.00) |
| Aug 15, 2016 | S Donald Sussman | 10% Owner | Buy | $0 (714,285 @ $0.00) |
| Aug 15, 2016 | Tomer Kariv | Director | Buy | $0 (263,017 @ $0.00) |
| Aug 15, 2016 | Arie Belldegrun | Director | Buy | $0 (714,285 @ $0.00) |
| Aug 15, 2016 | Tomer Kariv | Director | Buy | $0 (102,100 @ $0.00) |
| Jan 12, 2016 | Steven B Ruchefsky | Director | Buy | $1.0M (2,876,633 @ $0.35) |
| Jan 12, 2016 | Tomer Kariv | Director | Buy | $248K (707,868 @ $0.35) |
| Jan 12, 2016 | Arie Belldegrun | Director | Buy | $507K (1,448,062 @ $0.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.